Popular Science

News

Focus on corporate dynamics,Insight into development frontiers

FDA approves NGS blood test oversized panel, a new milestone in liquid biopsy

FDA approves NGS blood test oversized panel, a new milestone in liquid biopsy

On May 20, 2026, Guardant Health, a global leader in liquid biopsy, announced that the U.S. Food and...

Novel Therapeutic Strategies for Biliary Tract Tumors: A Comprehensive Comprehension of Genetic Testing for Biliary Trac

Novel Therapeutic Strategies for Biliary Tract Tumors: A Comprehensive Comprehension of Genetic Testing for Biliary Trac

On May 21, 2026, the official website of the Center for Drug Evaluation (CDE) declared that the IDH1...

MRD Strategy Following the FDA’s Breakthrough

MRD Strategy Following the FDA’s Breakthrough

On May 15, 2026, the U.S. Food and Drug Administration (FDA) issued an approval document, for the fi...

2026 CSCO Update: A Comprehensive Look at the Management of Non - Small Cell Lung Cancer Diagnosis and Treatment

2026 CSCO Update: A Comprehensive Look at the Management of Non - Small Cell Lung Cancer Diagnosis and Treatment

From the perspective of the 2026 update of the guidelines of the Chinese Society of Clinical Oncology...

A New Perspective on the Diagnosis and Treatment of Glioma: How Do MET Gene Changes Affect the Survival of Patients with

A New Perspective on the Diagnosis and Treatment of Glioma: How Do MET Gene Changes Affect the Survival of Patients with

IntroductionGliomas are the most prevalent malignant brain tumors, accounting for approximately 80% of all malignant...

Without Driver Alterations, Whither The Treatment Paradigm?

Without Driver Alterations, Whither The Treatment Paradigm?

Without Driver Alterations, Whither The Treatment Paradigm? 2026 ASCO Dynamic Update: Treatment of Advanced NSCLC without Driver Gene Mutation